This study has provided theoretical reference for further study on the anti-tumor mechanism of VP-16.
从而为医学工作者进一步了解和探讨VP-16的抗肿瘤机理提供了直接的理论依据。
CONCLUSION: Intrapericardial infusion of VP-16 and DDP is an effective treatment for malignant pericardial effusion of NSCLC.
结论：心包穿刺抽液加心包腔内注入VP - 16联合DDP是恶性心包积液有效的治疗方法。
Methods 56 patients with SCLC were randomly divided into treatment group and control group receiving ce (Carboplatin, Etoposide VP-16) regimen plus Lifein or ce regimen alone respectively.
方法将56例小细胞肺癌患者以随机方式分为治疗组ce(卡铂、VP - 16)方案化疗并用力尔凡和对照组单用CE方案化疗。
Methods 56 patients with SCLC were randomly divided into treatment group and control group receiving ce (Carboplatin, Etoposide VP-16) regimen plus Lifein or ce regimen alone respectively.
方法将56例小细胞肺癌患者以随机方式分为治疗组ce(卡铂、VP - 16)方案化疗并用力尔凡和对照组单用CE方案化疗。
应用推荐